Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

60 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Epstein-Barr virus and mismatch repair deficiency status differ between oesophageal and gastric cancer: A large multi-centre study.
Hewitt LC, Inam IZ, Saito Y, Yoshikawa T, Quaas A, Hoelscher A, Bollschweiler E, Fazzi GE, Melotte V, Langley RE, Nankivell M, Cunningham D, Allum W, Hutchins GG, Grabsch HI. Hewitt LC, et al. Among authors: melotte v. Eur J Cancer. 2018 May;94:104-114. doi: 10.1016/j.ejca.2018.02.014. Epub 2018 Mar 20. Eur J Cancer. 2018. PMID: 29550565 Free PMC article.
Histological intratumoral heterogeneity in pretreatment esophageal cancer biopsies predicts survival benefit from neoadjuvant chemotherapy: results from the UK MRC OE02 trial.
Davarzani N, Hewitt LC, Hale MD, Melotte V, Nankivell M, Hutchins GGA, Cunningham D, Allum WH, Langley RE, Jolani S, Grabsch HI. Davarzani N, et al. Among authors: melotte v. Dis Esophagus. 2020 Aug 3;33(8):doaa058. doi: 10.1093/dote/doaa058. Dis Esophagus. 2020. PMID: 32591823 Free PMC article.
Tumour infiltrating lymphocytes and survival after adjuvant chemotherapy in patients with gastric cancer: post-hoc analysis of the CLASSIC trial.
Liu DHW, Kim YW, Sefcovicova N, Laye JP, Hewitt LC, Irvine AF, Vromen V, Janssen Y, Davarzani N, Fazzi GE, Jolani S, Melotte V, Magee DR, Kook MC, Kim H, Langer R, Cheong JH, Grabsch HI. Liu DHW, et al. Among authors: melotte v. Br J Cancer. 2023 Jun;128(12):2318-2325. doi: 10.1038/s41416-023-02257-3. Epub 2023 Apr 7. Br J Cancer. 2023. PMID: 37029200 Free PMC article. Clinical Trial.
GATA4 and GATA5 are potential tumor suppressors and biomarkers in colorectal cancer.
Hellebrekers DM, Lentjes MH, van den Bosch SM, Melotte V, Wouters KA, Daenen KL, Smits KM, Akiyama Y, Yuasa Y, Sanduleanu S, Khalid-de Bakker CA, Jonkers D, Weijenberg MP, Louwagie J, van Criekinge W, Carvalho B, Meijer GA, Baylin SB, Herman JG, de Bruïne AP, van Engeland M. Hellebrekers DM, et al. Among authors: melotte v. Clin Cancer Res. 2009 Jun 15;15(12):3990-7. doi: 10.1158/1078-0432.CCR-09-0055. Epub 2009 Jun 9. Clin Cancer Res. 2009. PMID: 19509152
The CpG island methylator phenotype: what's in a name?
Hughes LA, Melotte V, de Schrijver J, de Maat M, Smit VT, Bovée JV, French PJ, van den Brandt PA, Schouten LJ, de Meyer T, van Criekinge W, Ahuja N, Herman JG, Weijenberg MP, van Engeland M. Hughes LA, et al. Among authors: melotte v. Cancer Res. 2013 Oct 1;73(19):5858-68. doi: 10.1158/0008-5472.CAN-12-4306. Epub 2013 Jun 25. Cancer Res. 2013. PMID: 23801749
Author Correction: Analysis of DNA methylation in cancer: location revisited.
Koch A, Joosten SC, Feng Z, de Ruijter TC, Draht MX, Melotte V, Smits KM, Veeck J, Herman JG, Van Neste L, Van Criekinge W, de Meyer T, van Engeland M. Koch A, et al. Among authors: melotte v. Nat Rev Clin Oncol. 2018 Jul;15(7):467. doi: 10.1038/s41571-018-0028-9. Nat Rev Clin Oncol. 2018. PMID: 29713045
Intestinal multicellular organoids to study colorectal cancer.
Idris M, Alves MM, Hofstra RMW, Mahe MM, Melotte V. Idris M, et al. Among authors: melotte v. Biochim Biophys Acta Rev Cancer. 2021 Dec;1876(2):188586. doi: 10.1016/j.bbcan.2021.188586. Epub 2021 Jun 30. Biochim Biophys Acta Rev Cancer. 2021. PMID: 34216725 Free article. Review.
60 results